Adipositas - Ursachen, Folgeerkrankungen, Therapie 2021; 15(03): 150
DOI: 10.1055/s-0041-1735670
Abstracts
Wiesbaden: Adipositas-Kongress 2021
5 Weight-Loss Maintenance with Once-Weekly Semaglutide 2.4 mg in Adults with Overweight
or Obesity Reaching Maintenance Dose (STEP 4)
Authors
-
Domenica Rubino
1
Washington Center for Weight Management, Arlington, USA
-
Niclas Abrahamsson
2
Uppsala University, Uppsala, Schweden
-
Melanie Davies
3
University of Leicester, Leicester, Vereinigtes Königreich
-
Dan Hesse
4
Novo Nordisk, Soborg, Dänemark
-
Frank Greenway
5
Louisiana State University System, Baton Rouge, USA
-
Camilla Jensen
4
Novo Nordisk, Soborg, Dänemark
-
Ildiko Lingvay
6
Southwestern Medical Center, Dallas, USA
-
Tanja Wiedenmann
7
Novo Nordisk, Mainz, Deutschland
-
Ofri Mosenzon
8
Hebrew University of Jerusalem, Jerusalem, Israel
-
Julio Rosenstock
9
Dallas Diabetes Research Center at Medical City, Dallas, USA
-
Miguel Rubio
10
Hospital Clínico Universitario San Carlos and Instituto de Investigación Sanitaria
del Hospital Clínico San Carlos, Madrid, Spanien
-
Gottfried Rudolfsky
11
Cantonal Hospital, Olten, Schweiz
-
Sayeh Tadayon
4
Novo Nordisk, Soborg, Dänemark
-
Thomas Wadden
12
University of Pennsylvania, Philadelphia, USA
-
Dror Dicker
13
Tel Aviv University, Tel Aviv, Israel
